Showing results (191-200 of 198) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Cell Death Discovery|August 24, 2016
Necrotic enlargement of cone photoreceptor cells and the release of high-mobility group box-1 in retinitis pigmentosaY Murakami, Y Ikeda, S Nakatake, et al.
Seizure|November 25, 2003
When might hemispheric favouring of epileptiform discharges begin?M J Doherty, E Simon, M S De Menezes, et al.
Cell Death and Differentiation|August 20, 2013
Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degenerationY Murakami, H Matsumoto, M Roh, et al.
Environmental Science & Technology|August 14, 2009
Comprehensive simultaneous shipboard and airborne characterization of exhaust from a modern container ship at seaShane M Murphy, Harshit Agrawal, Armin Sorooshian, et al.
Journal of Medical Engineering & Technology|January 20, 2016
Treadmill measures of ambulation rates in ovine models of spinal cord injury and neuropathic painS Safayi, J W Miller, S Wilson, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 25, 1999
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 studyJ W Miller, U Schmidt-Erfurth, M Sickenberg, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 18, 2000
A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causesM Sickenberg, U Schmidt-Erfurth, J W Miller, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 25, 1999
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 studyU Schmidt-Erfurth, J W Miller, M Sickenberg, et al.
Pageof 20